CeeTox featured in May 2008 GEN article
Posted Tuesday, June 17, 2008
CeeTox is featured in an article by Genetic Engineering & Biotechnology News entitled “Introducing In Vitro ADMET Studies Earlier”
“We combine the results of nine different biochemical assays to predict the point at which toxicity will first occur in vivo and give detailed information on subcellular sites of toxicity, all designed to expedite the lead-optimization process,” said Dr. [Jim] McKim.
“We provide in vitro assays that evaluate CYP enzyme induction, metabolic activation, and CYP inhibition to evaluate the drug-drug interaction potential of a compound. We also evaluate cardiotoxicity, lipidosis, endocrine interactions, and antitumor candidates.”
View “Introducing In Vitro ADMET Studies Earlier” at genengnews.com